drugset / Trial / NCT07069933

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

NCT07069933

Phase 2 Not yet recruiting 50 enrolled Mansoura University
RandomizedParallel-groupDouble-blindPrevention

Summary

A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of Itraconazole as an adjuvant therapy in treatment of patients with acute myeloid Leukemia.

Timeline

Start
2025-07
Primary completion
2025-07
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Itraconazole Small molecule 200 mg